Literature DB >> 15516381

Treatment of recurrent bacterial vaginosis with tinidazole.

F Ariella Baylson1, Paul Nyirjesy, M Velma Weitz.   

Abstract

BACKGROUND: Recurrent bacterial vaginosis is a difficult clinical condition. In women with recurrent bacterial vaginosis, relapses are common, even after prolonged courses of maintenance therapy. Because of its spectrum of activity, tinidazole was used in a patient with recurrent bacterial vaginosis. CASE: A 23-year-old woman taking oral contraceptives had a single sexual partner. She was treated for recurrent bacterial vaginosis with multiple courses of metronidazole gel 0.75%, including regimens of maintenance therapy. The patient experienced repeated recurrences shortly after stopping treatment. A single course of oral tinidazole resulted in a prolonged period where she was free of bacterial vaginosis.
CONCLUSION: Treatment options for recurrent bacterial vaginosis are currently limited. Tinidazole may be a useful option in women with recurrent bacterial vaginosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516381     DOI: 10.1097/01.AOG.0000141551.67833.06

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics.

Authors:  Rebecca M Brotman; Emily J Erbelding; Roxanne M Jamshidi; Mark A Klebanoff; Jonathan M Zenilman; Khalil G Ghanem
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-08       Impact factor: 1.814

2.  A comparative study of oral single dose of metronidazole, tinidazole, secnidazole and ornidazole in bacterial vaginosis.

Authors:  Jyoti Thulkar; Alka Kriplani; Nutan Agarwal
Journal:  Indian J Pharmacol       Date:  2012-03       Impact factor: 1.200

3.  Randomized, double-blind, comparative study of oral metronidazole and tinidazole in treatment of bacterial vaginosis.

Authors:  Indu M Raja; Asha Basavareddy; Deepali Mukherjee; Bikash Ranjan Meher
Journal:  Indian J Pharmacol       Date:  2016 Nov-Dec       Impact factor: 1.200

4.  Guidelines for the treatment of bacterial vaginosis: focus on tinidazole.

Authors:  Laura J Dickey; Michael D Nailor; Jack D Sobel
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.